Research
Scientific articles on peptide research, documentation, purity, and traceability.
Alpha Research
cellular longevity
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper): Copper Chelation Chemistry, MMP Modulation, TGF-β1 Activation, and Pleiotropic Tissue Remodeling
Comprehensive biochemical analysis of GHK-Cu: copper-tripeptide complex stability, TGF-β1/Smad2/3 activation, differential MMP-1/TIMP-1/TIMP-2 regulation, Wnt/β-catenin signalling, and implications for tissue remodeling research.
Alpha Research
Growth hormone
Somatopause: Age-Related Decline in GH Pulsatility, Elevated Somatostatin Tone, and the GHS-R1a Research Rationale
Review of the neuroendocrine mechanisms underlying somatopause: reduced GH pulse amplitude, elevated somatostatin tone, GHS-R1a density decline, and the rationale for secretagogue research protocols in aging models.
Alpha Research
Growth hormone
GH Axis Peptides and Body Composition Research: Lipolysis, Lean Mass Accretion, and IGF-1 Mediation
Analysis of the molecular mechanisms by which GH axis secretagogues modulate adipose lipolysis, skeletal muscle protein synthesis, and hepatic IGF-1 biogenesis in preclinical and clinical research models.
Alpha Research
Growth hormone
GHRP vs GHRH: Ghrelin Receptor vs GHRH Receptor Mechanisms and Combinatorial Research Rationale
Comparative pharmacological analysis of GHS-R1a and GHRH-R mechanisms: second messengers, GH release kinetics, somatostatin modulation, and the mechanistic rationale for combinatorial research protocols.
Alpha Research
Growth hormone
Tesamorelin vs Sermorelin: Structural Stability, GHRH-R Binding Kinetics, and Comparative Pharmacokinetic Profiles
Mechanistic comparison of tesamorelin and sermorelin: trans-3-hexenoyl structural modifications conferring DPP-IV stability, GHRH-R binding kinetics, comparative pharmacokinetic parameters (t½, bioavailability, Cmax), and GH AUC response in research models.
Alpha Research
Growth hormone
IGF-1 Axis Activation via GH Secretagogues: Hepatic IGF-1 Synthesis, IGF-1R/IRS-1 Signaling, and Anabolic Research Models
Analysis of GH-mediated hepatic IGF-1 synthesis: JAK2/STAT5b signaling, IGF-1R/IRS-1/PI3K/Akt/mTOR activation, inhibitory feedback on the GH axis, and percentage IGF-1 change data in preclinical research models.
Alpha Research
Growth hormone
GH Secretory Dynamics During Slow-Wave Sleep: Delta Wave Coupling, GH Pulse Amplitude, and Sleep EEG Research
Analysis of neuroendocrine GH regulation during slow-wave sleep: electrophysiological coupling with delta waves, GHRH mechanisms, quantitative EEG data, impact of sleep fragmentation on GH AUC, and relevance to secretagogue research models.
Alpha Research
Growth hormone
Endogenous GH Regulation: GHRH/Somatostatin Balance, Sleep Architecture, and Pharmacological Research Targets
Analysis of hypothalamo-pituitary GH regulation: the GHRH/somatostatin axis, SSTR1-5 receptor subtypes, slow-wave sleep coupling with GH pulses, and pharmacological targets relevant to secretagogue research.
Alpha Research
Growth hormone
CJC-1295 + Ipamorelin: Synergistic GHRH/GHS-R1a Dual Axis Stimulation and Mechanistic Research Rationale
Mechanistic analysis of CJC-1295 and ipamorelin co-administration: convergence at the somatotroph, cAMP/PKA/CREB signaling, somatostatinergic tone modulation, and comparative pharmacokinetic data for preclinical research models.
Alpha Research
Growth hormone
Ipamorelin vs Sermorelin: Receptor Selectivity, GH Pulse Architecture, and IGF-1 Response Profiles
Head-to-head technical comparison of ipamorelin (GHS-R1a agonist, ghrelin class) versus sermorelin (GHRH-R agonist, GHRH class): differential signaling mechanisms, receptor selectivity, GH pulse architecture, comparative pharmacokinetics, and IGF-1 responses in preclinical and clinical models.
Alpha Research
Growth hormone
Tesamorelin: Trans-2-Hexadecenoyl GHRH Analogue, GH Secretion Kinetics, and Visceral Adiposity Research Data
Technical review of tesamorelin as an N-terminally modified GHRH(1–44) analogue with trans-2-hexadecenoyl group: pharmacokinetics (t½ ~26 min SC), GHRH-R activation, GH/IGF-1 AUC data, and visceral fat reduction data from phase 3 clinical trials (mean 15% VAT reduction, p<0.001).
Alpha Research
Growth hormone
Sermorelin Acetate: GHRH(1-29) Analogue, Pituitary Somatotroph Activation, and Research Pharmacokinetics
Technical review of sermorelin acetate as a GHRH(1–29) analogue: GHRH-R receptor activation mechanism via cAMP/PKA/CREB, pituitary somatotrophs, GH secretion kinetics (t½ ~10–12 min), IGF-1 response, and clinical study data in adult GH-deficient subjects.